Taxus launch in Japan
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific launches its Taxus Express2 paclitaxel-eluting stent in Japan May 8. The firm secured reimbursement from Japan's National Health Insurance System May 1 for the device, which gained Ministry of Health, Labor and Welfare approval in late March. Taxus joins Johnson & Johnson/Cordis' Cypher, the only drug-eluting stent on the Japanese market (1"The Gray Sheet" April 9, 2007, p. 17)...